Eric Langer, Managing partner at BioPlan Associates, speaks with BioPharm International about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Eric Langer, Managing Partner at BioPlan Associates, spoke with BioPharm International about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.